Download FREE Report Sample
Download Free sampleDengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
Dengue Virus Diagnostic Tests Market contains market size and forecasts of Dengue Virus Diagnostic Tests in Global, including the following market information:
Global Dengue Virus Diagnostic Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Dengue Virus Diagnostic Tests market was valued at 3344.4 million in 2021 and is projected to reach US$ 4251.7 million by 2028, at a CAGR of 3.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dengue NS1Ag Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dengue Virus Diagnostic Tests include Alere, Biogate, NovaBios Laboratories Diagnostics, Rapikit, Wondfo, BTNX, GENESIS, Boson Biotech and Adaltis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dengue Virus Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dengue Virus Diagnostic Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dengue Virus Diagnostic Tests Market Segment Percentages, by Type, 2021 (%)
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test
Global Dengue Virus Diagnostic Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dengue Virus Diagnostic Tests Market Segment Percentages, by Application, 2021 (%)
Hospital
Research Institution
Others
Global Dengue Virus Diagnostic Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dengue Virus Diagnostic Tests Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dengue Virus Diagnostic Tests revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Dengue Virus Diagnostic Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
